Published in Eur J Vasc Endovasc Surg on October 20, 2006
Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. J Am Coll Cardiol (2015) 1.54
Assessment of functional status and quality of life in claudication. J Vasc Surg (2011) 0.98
Exercise training and peripheral arterial disease. Compr Physiol (2012) 0.90
Peripheral arterial disease. BMJ Clin Evid (2011) 0.77
The Oslo Balloon Angioplasty versus Conservative Treatment Study (OBACT) - The 2-years results of a single centre, prospective, randomised study in patients with intermittent claudication. Eur J Vasc Endovasc Surg (2007) 0.75
Letter to the editor, re: Nylaende M, Abdelnoor M, Stranden E, Morken B, Sandbaek G, Risum O, et al. The Oslo balloon angioplasty versus conservative treatment study (OBACT)--the 2-years results of a single centre, prospective, randomised study in patients with intermittent claudication. Eur J Vasc Endovasc Surg. 2007;33:3-12. Eur J Vasc Endovasc Surg (2007) 0.75
Commentary: Nylaende M, Abdelnoor M, Stranden E, et al. The Oslo Balloon Angioplasty versus Conservative Treatment Study (OBACT)--the 2-years results of a single centre, prospective, randomised study in patients with intermittent claudication. Eur J Vasc Endovasc Surg. 2007;33:3-12. Perspect Vasc Surg Endovasc Ther (2007) 0.75
Peripheral arterial disease. BMJ Clin Evid (2007) 0.75
Validation of the Vascular quality of life questionnaire - 6 for clinical use in patients with lower limb peripheral arterial disease. Health Qual Life Outcomes (2017) 0.75
Lumbar spinal stenosis: conservative or surgical management?: A prospective 10-year study. Spine (Phila Pa 1976) (2000) 3.69
The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med (1990) 2.85
Lumbar spinal stenosis. Clinical and radiologic features. Spine (Phila Pa 1976) (1995) 2.37
Tranexamic acid (Cyklokapron) is not necessary to reduce blood loss after coronary artery bypass operations. J Thorac Cardiovasc Surg (1993) 2.25
Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke. Lancet (1992) 2.22
Follow-up and final results of the Oslo I Study comparing screen-film mammography and full-field digital mammography with soft-copy reading. Acta Radiol (2005) 2.16
The association between the proximal extension of the clot and the severity of pulmonary embolism (PE): a proposal for a new radiological score for PE. J Intern Med (2007) 2.07
Thrombolytic therapy for acute myocardial infarction in older patients. Lancet (1996) 2.03
Sternal wound infections in patients undergoing open heart surgery: randomized study comparing intracutaneous and transcutaneous suture techniques. Ann Thorac Surg (2001) 2.00
Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency. J Thromb Haemost (2009) 1.95
Prolonged thromboprophylaxis following hip replacement surgery--results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin) Thromb Haemost (1997) 1.73
Panic disorder in chest pain patients referred for cardiological outpatient investigation. J Intern Med (1999) 1.55
Adipose tissue pro-inflammatory gene expression is associated with cardiovascular disease. Int J Clin Pract (2011) 1.54
Treatment of Raynaud's phenomenon with the 5-HT2-receptor antagonist ketanserin. Br Med J (Clin Res Ed) (1982) 1.52
Validity of an exam assessment in surgical skill: EBSQ-VASC pilot study. Eur J Vasc Endovasc Surg (2004) 1.48
Management of suspected pulmonary embolism (PE) by D-dimer and multi-slice computed tomography in outpatients: an outcome study. J Thromb Haemost (2005) 1.45
Mortality and morbidity after coronary artery bypass surgery related to pre-operative left ventricular ejection fraction: a follow-up study. Eur Heart J (1996) 1.41
Dietary intake of differently fed salmon; the influence on markers of human atherosclerosis. Eur J Clin Invest (2005) 1.30
Streptokinase of heparin in the treatment of deep vein thrombosis. Follow-up results of a prospective study. Acta Med Scand (1982) 1.24
Blood pressure in patients with intermittent claudication increases continuously during walking. Eur J Vasc Endovasc Surg (2006) 1.16
Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol (1996) 1.15
A controlled clinical trial of streptokinase and heparin in the treatment of major pulmonary embolism. Acta Med Scand (1978) 1.14
Mean HbA1c over 18 years predicts carotid intima media thickness in women with type 1 diabetes. Diabetologia (2005) 1.06
Risk factors in primary sclerosing cholangitis. J Hepatol (1994) 1.04
Myocardial damage during percutaneous transluminal coronary angioplasty as evidenced by troponin T measurements. Eur Heart J (1998) 1.04
Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET). Thromb Haemost (2000) 1.03
Health and cost consequences of surgical versus conservative treatment for a comminuted proximal humeral fracture in elderly patients. Injury (2009) 1.02
Ketanserin in intermittent claudication: effect on walking distance, blood pressure, and cardiovascular complications. J Cardiovasc Pharmacol (1987) 1.02
Demonstration of platelet-derived microvesicles in blood from patients with activated coagulation and fibrinolysis using a filtration technique and western blotting. Thromb Haemost (1994) 1.00
Long-term effects of n-3 polyunsaturated fatty acids on haemostatic variables and bleeding episodes in patients with coronary artery disease. Blood Coagul Fibrinolysis (1995) 0.99
Capillary supply in soleus and gastrocnemius muscles of man. Pflugers Arch (1978) 0.98
Cerebral microembolic signals during cardiopulmonary bypass surgery. Frequency, time of occurrence, and association with patient and surgical characteristics. Stroke (1997) 0.98
Diabetes mellitus and morbidity and mortality risks after coronary artery bypass surgery. Scand J Thorac Cardiovasc Surg (1996) 0.98
Increased activation of coagulation and formation of late deep venous thrombosis following discontinuation of thromboprophylaxis after hip replacement surgery. Thromb Res (1995) 0.97
n-3 polyunsaturated fatty acids and cardiovascular diseases. Lipids (2001) 0.97
Effects of anthocyanins on cardiovascular risk factors and inflammation in pre-hypertensive men: a double-blind randomized placebo-controlled crossover study. J Hum Hypertens (2012) 0.97
Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individuals. J Clin Microbiol (2001) 0.96
Combined administration of dextran 70 and dalteparin does not increase perioperative blood loss compared to dextran 70 alone in major orthopedic surgery. Haemostasis (1999) 0.95
The effect of supplementation with omega-3 fatty acids on soluble markers of endothelial function in patients with coronary heart disease. Arterioscler Thromb Vasc Biol (1999) 0.93
Elevated TFPI in malignant disease: relation to cancer type and hypercoagulation. Br J Haematol (1998) 0.92
Sequential intrapulmonary and systemic activation of coagulation and fibrinolysis during and after total hip replacement surgery. Thromb Res (1993) 0.92
Complement activation in injured patients occurs immediately and is dependent on the severity of the trauma. Injury (1998) 0.91
A prospective study of streptokinase and heparin in the treatment of deep vein thrombosis. Acta Med Scand (1978) 0.91
Sustained prothrombotic profile after hip replacement surgery: the influence of prolonged prophylaxis with dalteparin. J Thromb Haemost (2003) 0.91
Inflammatory responses after percutaneous coronary intervention in patients with acute myocardial infarction or stable angina pectoris. Scand J Clin Lab Invest (2008) 0.90
A comparison between surface measurements and water displacement volumetry for the quantification of leg edema. J Oslo City Hosp (1981) 0.90
Health-related quality of life in narcolepsy. Acta Neurol Scand (2006) 0.90
Blood glucose lowering by means of lifestyle intervention has different effects on adipokines as compared with insulin treatment in subjects with type 2 diabetes. Diabetologia (2006) 0.90
Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): levels in the normal population and relation to cholesterol. Blood Coagul Fibrinolysis (1991) 0.89
The performance of STA-Liatest D-dimer assay in out-patients with suspected pulmonary embolism. Br J Haematol (2006) 0.89
Increased platelet aggregability during exercise in patients with previous myocardial infarction. Lack of inhibition by aspirin. Thromb Res (2000) 0.89
Undiagnosed dysglycaemia and inflammation in cardiovascular disease. Eur J Clin Invest (2006) 0.88
Endothelial cell adhesion molecules in healthy adults during acute hyperhomocysteinemia and mild hypertriglyceridemia. Clin Biochem (2004) 0.88
Radon in dwellings and lung cancer-a discussion. Health Phys (1980) 0.88
Supervised exercise training reduces plasma levels of the endothelial inflammatory markers E-selectin and ICAM-I in patients with peripheral arterial disease. Angiology (2011) 0.87
Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers. Eur J Clin Invest (1998) 0.87
The effect of angiotensin II receptor antagonism with losartan on glucose metabolism and insulin sensitivity. J Hypertens (1996) 0.87
2 -Macroglobulin, 1 -antitrypsin, and antithrombin III in plasma and serum during fibrinolytic therapy with urokinase. Scand J Clin Lab Invest (1972) 0.87
Changes in serum levels of E-selectin correlate to improved glycaemic control and reduced obesity in subjects with the metabolic syndrome. Scand J Clin Lab Invest (2005) 0.87
Endogenous thrombin potential (ETP) in plasma from patients with AMI during antithrombotic treatment. Thromb Res (2008) 0.86
Complement and granulocyte activation in two different types of heparinized extracorporeal circuits. J Thorac Cardiovasc Surg (1995) 0.86
Stenting for chronic post-thrombotic vena cava and iliofemoral venous occlusions: mid-term patency and clinical outcome. Eur J Vasc Endovasc Surg (2010) 0.86
Effects of long-term anticoagulant therapy in subgroups after acute myocardial infarction. Arch Intern Med (1992) 0.86
Effects on coagulation and fibrinolysis with reduced versus full systemic heparinization and heparin-coated cardiopulmonary bypass. Circulation (1995) 0.85
Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants. Arterioscler Thromb Vasc Biol (1997) 0.85
Serum cardio-specific troponin T after open heart surgery in patients with and without perioperative myocardial infarction. Scand J Clin Lab Invest (1994) 0.85
D-dimer level is associated with the extent of pulmonary embolism. Thromb Res (2006) 0.85
Reduced levels of TNF alpha in hypercholesterolemic individuals after treatment with pravastatin for 8 weeks. Atherosclerosis (2001) 0.84
Cancer incidence among workers exposed to radon and thoron daughters at a niobium mine. Scand J Work Environ Health (1985) 0.84